Reversing Age with Science: Ryan Smith on Epigenetics, Peptides, and the Future of Longevity
[HPP] Ryan SmithJuly 12, 202559 min
27 connectionsΒ·40 entities in this videoβRyan Smith's Journey to Longevity Science
- π Ryan Smith transitioned from medical school and founding Tailor Made Compounding (peptides) to becoming the Chief Scientific Officer of TruDiagnostic, focusing on epigenetic science.
- π‘ His journey was driven by a desire to quantify the effectiveness of interventions and a recognition of the limitations of traditional pharmaceutical development.
Understanding Biological vs. Chronological Age
- π― Chronological age is simply the number of years lived, while biological age reflects molecular and physical health, offering a more predictive measure of health outcomes.
- π Biological age is a much more informative and predictive factor for disease risk and lifespan than chronological age.
The Power of Epigenetics and DNA Methylation
- 𧬠Epigenetics measures how genes are turned on or off (gene expression), which is dynamic and influenced by lifestyle, unlike static DNA.
- π¬ DNA methylation involves attaching a carbon group to cytosine in DNA, acting as an "off switch" for genes and serving as a log of life's experiences and behaviors.
- π‘ TruDiagnostic uses artificial intelligence to read these methylation patterns, creating algorithms that predict health outcomes, disease risk, and even lifestyle factors.
TruDiagnostic's Comprehensive Testing
- β The Biological Age Test includes algorithms like Omic Age (predicts lifespan, identifies aging drivers), Symphony Age (organ-specific aging), and Dunan Pace (instantaneous rate of aging, highly correlated to health span).
- π The True Health Report predicts over 1,700 biomarkers (vitamins, hormones, neurotransmitters, clinical function) from a single blood drop, often proving more predictive than classical blood tests due to measuring longer average concentrations.
- π Future developments include food and diet insights, disease risk prediction (e.g., Alzheimer's, cardiovascular disease), and companion diagnostics for GLP-1s to predict individual responses and side effects.
Interventions and Future Outlook
- π§ͺ TruDiagnostic has conducted over 120 interventional trials, identifying effective strategies like hyperbaric oxygen and SGLT2 inhibitors for healthy populations.
- π° The company is pursuing FDA approval for an aging test, aiming to make highly accessible, low-cost preventative healthcare a reality, potentially replacing traditional blood tests.
Knowledge graph40 entities Β· 27 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
40 entities
Chapters18 moments
Key Moments
Transcript221 segments
Full Transcript
Topics15 themes
Whatβs Discussed
EpigeneticsPeptidesLongevityBiological AgeDNA MethylationGene ExpressionTruDiagnosticOmic AgeSymphony AgeDunan PaceBiomarkersInterventional TrialsPreventative HealthHealth SpanFDA Approval
Smart Objects40 Β· 27 links
PeopleΒ· 4
ConceptsΒ· 18
ProductsΒ· 8
EventsΒ· 2
CompaniesΒ· 8